tbuckley/cabot-search huggingface dataset:
Reduced FDG Uptake in the Brain on Baseline 18FDG PET/CT Predicts Worse Prognosis of Newly Diagnosed Intravascular Large B-Cell Lymphoma and Advanced-Stage Diffuse Large B-Cell Lymphoma
Authors: Hajime Senjo, Shinpei Harada, Koh Izumiyama, Hideki Goto, Shiro Watanabe, Keito Suto, Masayo Yamamoto, Kazuya Sato, Yasutaka Kakinoki, Tomoyuki Saga, Akio Shigematsu, Hiroto Horiguchi, Mutsumi Takahata, Reiki Ogasawara, Satoshi Yamamoto, Keisuke Yamaguchi, Kentaro Wakasa, Tetsuyuki Igarashi, Yoshihito Haseyama, Shinichi Ito, Katsuya Fujimoto, Junichi Hashiguchi, Junichi Sugita, Masao Nakagawa, Kenji Hirata, Takuto Miyagishima, Daigo Hashimoto, Takanori Teshima
Journal: Blood (2024)
Phase 1 Study of Escalating Doses of Ibrutinib in Teddi-R with Isavuconazole for Relapsed and Refractory Primary DLBCL of the CNS
Authors: Mark Roschewski, Christopher Melani, Rahul Lakhotia, Tatyana Gavrilova, Jagan R. Muppidi, James D. Phelan, Michail S. Lionakis, Kieron Dunleavy, Lode J. Swinnen, Matthias Holdhoff, Catherine E. Lai, Sami Ibrahimi, Michael Glantz, Jan Drappatz, John A. Butman, Stefania Pittaluga, Kim Johnson, Candis Morrison, Nick Micheletti, John D. Heiss, William D. Figg, Elaine S. Jaffe, S. Percy Ivy, Richard Little, Louis M. Staudt, Wyndham H. Wilson
Journal: Blood (2024)
Study of PC-002 (Sepantronium Bromide), a First-in-Class Inhibitor of Deubiquitinases (DUBs) Targeting Myc Degradation in Relapsed/Refractory c-Myc Rearranged High-Grade B Cell Lymphoma (HGBCL): Updated Phase 2 Results
Authors: Sung-Soo Yoon, Zhiming Li, Seokjin Kim, Ki-Seong Eom, Keshu Zhou, Sung-Nam Lim, Xiaoxi Zhou, Ye Guo, Sung Yong Oh, Huilai Zhang, Hagop Youssoufian, Vernon Jiang, Zanchun Huang, Georgina Kilfoil, Xin Wang, Zhixiang Cao, Xiang LI, Yihai Lin, Alexander Wu, Yiyou Chen, Yuqin Song
Journal: Blood (2024)
Efficacy Outcomes By Minimal Residual Disease (MRD) Negativity in Patients with Relapsed or Refractory Multiple Myeloma Treated with Belantamab Mafodotin Plus Bortezomib and Dexamethasone Vs Daratumumab, Bortezomib, and Dexamethasone: Analysis from the Dreamm-7 Trial
Authors: Vania Hungria, Marek Hus, Pawel Robak, Vera Zherebtsova, Ana Carolina de Almeida Ribas, Marcelo Pitombeira de Lacerda, Kihyun Kim, Sebastian Grosicki, Irwindeep Sandhu, Christopher Ward, Astrid McKeown, Hena Baig, Jie Ma, Benjamin Lariviere, Benga Kazeem, Lydia Eccersley, Sumita Roy-Ghanta, Joanna Opalinska, Maria Victoria Mateos
Journal: Blood (2024)
Erythroid-Specific Chimerism Analysis after Allogeneic-Hematopoietic Stem Cell Transplantation Using a Human Leukocyte Antigen-Identical Sibling Donor in Sickle Cell Disease Patients
Authors: Gonzalo De Luna, Nicolas Hebert, Ivan Sloma, Florence Beckerich, Rabah Redjoul, Anoosha Habibi, Mathieu Leclerc, Vincent Parinet, Christine Robin, Cécile Pautas, Stephane Moutereau, Fatima Bensiradj, Meghan Perkins, France Pirenne, Dehbia Menouche, Pablo Bartolucci, Sébastien Maury
Journal: Blood (2024)
Impact of Atrial Fibrillation on Patients with Myeloproliferative Neoplasms
Authors: Rodrigo Ortega Pérez, Valentín García Gutiérrez, Alberto Alvarez Larran, Maria Angeles Foncillas, Francisca Ferrer Marin, Beatriz Cuevas, Clara Martínez Villaverde, Patricia Velez, Maria Isabel Mata Vazquez, Adrian Segura Diaz, Maria Laura Fox, Elvira Mora Casterá, Concepcion Ruiz Nuño, Jose Maria Raya Sanchez, Manuel Perez Encinas, Javier Loscertales, María Alicia Senin, Maria Soledad Noya Pereira, Mercedes Gasior Kabat, Blanca Xicoy, Concha Alaez, Gonzalo Carreño, Raul Perez Lopez, Rafael Andrés Del Orbe Barreto, María Angeles Goñi Herranz, Juan Manuel Alonso-Dominguez, Lucía Guerrero Fernández, Jose María Guerra, Anna Angona, Irene Pastor, Ana Pardo Sanz, Jose Luis Zamorano García
Journal: Blood (2024)
MRD and Molecular Risk Status Help to Define Optimal Maintenance Delivery Strategies after ASCT: Long Term Outcomes of the UK MRA Myeloma XI Trial Comparing Lenalidomide to Observation
Authors: Graham Jackson, Charlotte Pawlyn, Faith E Davies, Martin F Kaiser, Ruth M de Tute, Heather McIntyre, Jeanine Richards, Sharon Jackson, Elizabeth Hodson, Anna Hockaday, Catherine Olivier, John R Jones, Matthew W. Jenner, Gordon Cook, Walter Martin Gregory, Mark Drayson, Roger G Owen, David A. Cairns, Gareth Morgan
Journal: Blood (2024)
Multiomics Analysis of Paired Diagnosis and Relapse DLBCL Biopsies Shows a Reduction in T Cell Infiltration and Function at Relapse
Authors: Fiona Swain, Melinda Burgess, Sarah Kempe, Muhammed B. Sabdia, Andrea S Henden, Joel Wight, Eliza A. Hawkes, Howard Mutsando, Dipti Talaulikar, Lilia Merida de Long, Simone Birch, Penelope Wyche, Zachary Hawula, Rakin Chowdhury, Maher K. Gandhi, Colm Keane
Journal: Blood (2024)
Quality of Life during Survivorship Following Autologous Stem Cell Transplant for Mantle Cell Lymphoma
Authors: Mengyang Di, Carrie I Ho, Stephen D. Smith, Mazyar Shadman, Chaitra S. Ujjani, Ryan C. Lynch, Christina Poh, Vikram Raghunathan, Brian G. Till, Edus H. Warren, Ajay K. Gopal, Stephanie J. Lee
Journal: Blood (2024)
Estimating the Impact on Survival of Not Receiving CAR T Therapy Despite Being Eligible in Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Patients in Germany
Authors: Veit L. Buecklein, Francis A. Ayuk, Tobias A.W. Holderried, Christine Mai, Bradley Kievit, Rob Blisset, Brett Doble, Geoff Reid, Laura Reimeir, Caroline Bruns, Sachin Vadgama
Journal: Blood (2024)
Return to Work after Allogeneic HSCT: Further Insights in the Patients-Related Predictive Factors (The SOPRALLO Project)
Authors: Yana Stepanishyna, Sebastian Wittnebel, Fabio Andreozzi, Adriano Salaroli, Paulus Kristanto, Chloe Spilleboudt, Marie France Jaivenois, Sandra Michiels, Rezarta Ajazi, Charlotte Vandevoorde, Virginie De Wilde, Nathalie Meuleman, Philippe Lewalle, Dominique Bron, Sule Mine Bakanay Ozturk
Journal: Blood (2024)
Assessing the Impact of Cognitive Load on Resting State Tissue Oxygen Saturation in Adult Patients with Sickle Cell Disease
Authors: Lara Abdelmohsen, Nahom Mossazghi, Shidhartho Roy, Joel Dzidzorvi Kwame Disu, Elizabeth Meinert-Spyker, Christine Saber, Julia Xu, Sossena Wood
Journal: Blood (2024)
For Patients with Adverse-Risk Acute Myeloid Leukemia, Frontline FLAG Ida with Venetoclax Is Safe and Efficacious
Authors: Baher Krayem, Avraham Frisch, Tsila Zuckerman, Israel Henig, Dana Yehudai-Ofir, Boaz Nachmias, Hazim Khatib, Arnon Haran, Shlomzion Aumann
Journal: Blood (2024)
Low Dose Clodronate Improves Exercise Tolerance, Right Ventricular Function, and Alters Resident Lung Macrophage Phenotypes
Authors: Christina Lisk, Francesca I Cendali, Delany Swindle, Gemlyn George, Kathryn Louise Hassell, Rachelle Nuss, Angelo D'Alessandro, Paul Buehler, David Irwin
Journal: Blood (2024)
Electronic Patient-Reported Outcome (ePRO) Symptom Monitoring for Relapsed/Refractory Multiple Myeloma in Community Settings, Focusing on Bispecific Antibody Therapy
Authors: Benjamin A Derman, James H Essell, Michael A. Kolodziej, Lavi Kwiatkowsky, Geoffrey Calkins, Christina M Parrinello, Mustafa S Ascha
Journal: Blood (2024)
Elucidating the Somatic Genetic Rescue Underlying Del(20q) Myeloid Neoplasms
Authors: Mark Orland, Arda Durmaz, Carlos Bravo-Perez, Carmelo Gurnari, Luca Guarnera, Matteo D'Addona, Aashray Mandala, Christopher Haddad, Kartik Lakhotiya, Valeria Visconte, Jaroslaw Maciejewski
Journal: Blood (2024)
Determining Outcome in IgM Gammopathies: Integration of Molecular, Flow Cytometry and Clinical Factors in an International, Multicenter Series (the SAL-TO Study)
Authors: Irene Dogliotti, Cristina Jimenez, Veronica Peri, Martina Ferrante, Davide Musto, Silvio Mercadante, Gian Maria Zaccaria, Marco Ghislieri, Giulia Benevolo, Enrique M. Ocio, Araceli Rubio, Ilda Maria Murillo, Fernando Escalante, Carmen Aguilera, Aránzazu García Mateo, Alfonso Garcia de Coca, Roberto Hernandez, Julio Dávila-Valls, Federica Cavallo, Noemi Puig, Almudena Navarro Bailon, Veronica Gonzalez-Calle, Maria Eugenia Sarasquete, Miguel Alcoceba, Simone Ragaini, Michele Clerico, Chiara Consoli, Maria Garcia Alvarez, Carmen Chillon, Alejandro Medina, Marcos Gonzalez Diaz, Norma C. Gutierrez, Benedetto Bruno, Daniela Drandi, Simone Ferrero, Ramon García-Sanz
Journal: Blood (2024)
Ponatinib Safety Profile: An Analysis of 10 Years of Real-World Experience
Authors: Elias Jabbour, Delphine Rea, Mouna Bardey-Kanaan, Romuald Soichez, Nhan Thanh Nguyen, Deborah Kelly, Federica Rizzo, Petros Patos, Valentín García Gutiérrez
Journal: Blood (2024)
Evaluating Barriers to Enrolment into Multiple Myeloma (MM) Clinical Trials: Results from Health Care Professionals and Patient Survey from the UK Myeloma Research Alliance Equity, Diversity and Inclusivity (EDI) Working Group
Authors: Selina J Chavda, Marquita Camilleri, Andrew Hall, Laura Clayton, Fatjon Dekaj, Dunsi Bolarinwa, Chantelle Hughes, Doina Levinte, Eileen M Boyle, Martin F Kaiser, Rachel O'Malley, Emma Williams, Andie Guy, Pinkie Chambers, Sandra CM Quinn, Rakesh Popat
Journal: Blood (2024)
Spectrum: Phase II Study of Tislelizumab Plus Pemetrexed in Patients with Relapsed or Refractory (R/R) Primary Diffuse Large B-Cell Lymphoma (DLBCL) of the Central Nervous System (CNS): The Korean Cancer Study Group LY22-07
Authors: Tae Min Kim, Jung Sun Kim, Gyeong-Won Lee, Myung-Won Lee, Jeonghwan Youk, Hyun Jung Lee, Sung-Nam Lim, Soyeon Kim, Yoon Kyung Jeon, Chul-Kee Park, Dae Seog Heo
Journal: Blood (2024)
Five-Year Outcomes of Patients (Pts) with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Treated with Brexucabtagene Autoleucel (Brexu-cel) in ZUMA-2 Cohorts 1 and 2
Authors: Michael Wang, Andre Goy, Javier Munoz, Frederick L. Locke, Caron A. Jacobson, Brian T. Hill, John Timmerman, Ian W. Flinn, David B. Miklos, John M. Pagel, Marie José Kersten, Edouard Forcade, Max S. Topp, Roch Houot, Amer Beitinjaneh, Dan Zheng, Mengru Chang, Rhine Shen, Wangshu Zhang, Rita Damico Khalid, Ioana Kloos, Patrick M. Reagan
Journal: Blood (2024)
Evaluating a Multidisciplinary Model of Care for Inherited Bone Marrow Failure and Predisposition to Hematological Malignancy
Authors: Lucy C Fox, Nicole Den Elzen, Erin Goode, Kelsey Man, Lin Cheng, Stephanie Best, Jillian Francis, Laura Barth, Paul James, Karin A Thursky, Ashish Bajel, David S. Ritchie, Piers Blombery
Journal: Blood (2024)
Retrospective Evaluation of <i>BCR::ABL</i> Kinase Domain Mutation Profiles and Treatment Outcomes in Patients with Chronic Myeloid Leukemia to Confirm Clinical Relevance of in Vitro Sensitivity-Based Treatment Switch: Real-World Experience
Authors: Maria Agustina Perusini, Eleanore Louise Musick, Filza Gul, May Chiu, Mohammad Alwadi, Noora Obaidallah, Jaeyoon John Kim, Danielle Pyne, Jose-Mario Capo-Chichi, Dennis Dong Hwan Kim
Journal: Blood (2024)
Correlation of Patient-Reported Outcomes with Red Blood Cell Transfusion Reduction and Rise in Hemoglobin in Patients with Lower-Risk Myelodysplastic Syndromes in the IMerge Trial
Authors: Mikkael A. Sekeres, Valeria Santini, Amer M. Zeidan, Uwe Platzbecker, Rami S. Komrokji, Maria Diez-Campelo, Pierre Fenaux, Michael R. Savona, Yazan F. Madanat, David Valcarcel, Antoine Regnault, Kristin Creel, Nishan Sengupta, Souria Dougherty, Sheetal Shah, Libo Sun, Ying Wan, Shyamala Navada, Esther Natalie Oliva
Journal: Blood (2024)
How Does Cognition Impact Healthcare Transition Skills, Engagement and Utilization in Young Adults Living with Sickle Cell Disease?
Authors: Phalica Georges, Sophie Marsolais, Chrystelle Charles, Amer Yassine Hafsaoui, Jade Bergeron, Barbara Fritz, Nancy Van Synghel, Valerie Fraile, Nathalie Fournier, Melissa Leblanc, Lauren Arena, Serge Sultan, Nancy Robitaille, Leandra Desjardins, Nathalie Gaucher, Yves D Pastore, Stephanie Forte
Journal: Blood (2024)
Efficacy of Targeted Agents and Immune Checkpoint Inhibitors in Patients with Malignant Histiocytosis
Authors: Alanis Enid Rodriguez-Rosario, Aldo Adrian Acosta Medina, N. Nora Bennani, Gaurav Goyal, Aishwarya Ravindran, Karen L Rech, Gordon J Ruan, Mithun V Shah, Dongni Yi, Saurabh Zanwar, Jithma P Abeykoon, Ronald S Go
Journal: Blood (2024)
Results of the Molecular Response Evaluation and TKI Dose Adjustment in Chronic Myeloid Leukemia Patients in Prospective Study of Reduction and Discontinuation Treatment of TKI (READIT)
Authors: Oleg Shukhov, Margarita Gurianova, Ekaterina Chelysheva, Anna Petrova, Anastasiya Bykova, Irina Nemchenko, Andrey Sudarikov, Elena Kuzmina, Lyubov Gavrilova, Alina Kokhno, Anna Turkina
Journal: Blood (2024)
Disparities in Clinical Trial Participation Among Medicare Beneficiaries with Hematologic Malignancies from 2006 to 2019: A SEER-Medicare Analysis
Authors: Inna Y Gong, Meredith Rosenthal, Mark Soto, Bahar Rafinejad-Farahani, Joseph M Unger, Carmen E Guerra, Rena M Conti, Danielle Rodin
Journal: Blood (2024)
Absolute Risk of Multiple Myeloma Is Quite Modest in Individuals with Incidentally Discovered Vertebral Fractures: A Prospective Cohort Study of 9,065 CT-Scanned Danish General Population Individuals with Independent Validation in a UK General Population Cohort
Authors: Rasmus Rønnemoes, Anne Rudbeck Juhl, Shoaib Afzal, Stig Egil Bojesen, Boerge Groenne Nordestgaard, Michael Huy Cuong Pham, Klaus Fuglsang Kofoed, Jørgen Tobias Kühl, Andreas Fuchs, Per Ejlstrup Sigvardsen, Thomas S. Kristensen, Jesper Petersen, Andreas Glenthoej, Jens Helby
Journal: Blood (2024)
Impact of Different Therapeutic Regimen on Prognosis in CEBPAbZIP-Inf Acute Myeloid Leukemia
Authors: Jiajia Pan, Nianci Chen, Liping Mao, Yinjun Lou, Yi Zhang, Shanshan Suo, Yile Zhou, Chenying Li, Xia Li, Xueying Yang, Qing Ling, Wenle Ye, Xiangjie Lin, Huafeng Wang, Jie Jin
Journal: Blood (2024)
Probability of Switch of TKIs Treatment According to Baseline Features in a Large Chronic Myeloid Leukemia (CML) Population: Italian CML Network
Authors: Massimo Breccia, Valentina Giai, Tiziana Rosso, Patrizia Pregno, Fausto Castagnetti, Massimiliano Bonifacio, Isabella Capodanno, Mario Tiribelli, Fabio Stagno, Olga Mulas, Antonella Gozzini, Luigiana Luciano, Sara Galimberti, Andrea Patriarca, Giuseppe Lanzarone, Bruno Martino, Anna Guella, Anna Rita Scortechini, Carmen Fava, Claudio Fozza, Federica Sorà, Alessandro Maggi, Michele Pizzuti, Sara Freducci, Giuseppina Loglisci, Antonella Russo Rossi, Maria Laura Di Noi, Giuseppina Spinosa, Maria Teresa Santeramo, Grazia Sanpaolo, Giuseppe Pietrantuono, Clara Mannarella, Elisabetta Calistri, Eleonora Prete, Gianantonio Rosti, Fabrizio Pane, Giuseppe Saglio, Giovannino Ciccone, Giorgina Specchia
Journal: Blood (2024)
Dynamic Cerebral Autoregulation and Blood Pressure Oscillations Reveal the Severity of Autoregulatory Dysfunction in Sickle Cell Disease
Authors: Joel Dzidzorvi Kwame Disu, Lara Abdelmohsen, Nahom Mossazghi, Elizabeth Meinert-Spyker, Christine Saber, Julia Xu, Sossena Wood
Journal: Blood (2024)
Mechanism-Based Treatable Targets for Organ Damage and Pain in Sickle Cell Disease
Authors: Yugal Goel, Sirsendu Jana, Mya Arellano, Reina A Lomeli, Graham J Velasco, Donovan A Argueta, Richard Prince, Abdu I Alayash, Joel Friedman, Kalpna Gupta
Journal: Blood (2024)
Acute Stroke in Children with Sickle Cell Anemia without Abnormal Transcranial Doppler in a Hydroxyurea Trial in Uganda
Authors: Bill Wambaka, Amiirah Mpungu, Vincent Mboizi, Dennis Kalibala, Grace Nambatya, Susan Murungi, Maxencia Kabatabaazi, Phillip Kasirye, Deogratias Munube, Robert Opoka, Richard Idro, Nancy S. S. Green
Journal: Blood (2024)
CD74 Antibody Conjugated to an MCL1 Inhibitor (S227928) Combines Synergistically with Venetoclax to Enhance Killing of Acute Myeloid Leukemia
Authors: Donia M. Moujalled, Giovanna Pomilio, Thomas Morley, Veronique Litalien, Natasha S. Anstee, Sun Loo, Zhi-Han Yeoh, Clovis Boibessot, Laura Bresson, Ana-Leticia Maragno, Caroline Liot, Andrew H Wei
Journal: Blood (2024)
Outcomes with HMA Plus Venetoclax Vs Intensive Chemotherapy in AML Patients with Chromosome 5 and 7 Abnormalities
Authors: Leora Boussi, Jan Philipp Bewersdorf, Yiwen Liu, Rory M. Shallis, Luis E. Aguirre, Andrius Zucenka, Sylvain Garciaz, Rebecca P. Bystrom, Daniel J. DeAngelo, Richard M Stone, Marlise R. Luskin, Jacqueline S. Garcia, Eric S. Winer, Evan Chen, Martha Wadleigh, Kelly Ling, Amer M. Zeidan, Aaron D. Goldberg, Eytan M. Stein, Shai O. Shimony, Maximilian Stahl
Journal: Blood (2024)
An Inpatient Advance Care Planning Intervention for Older Patients with Hematologic Malignancies: A Single-Arm Pilot Study
Authors: Marissa Locastro, Ying Wang, Soroush Mortaz-Hedjri, Danielle Frumusa, Tracy Natale, Jessica Cohen, Nicole Yates, Jenna Podlucky, Tristan Yu, Thomas Carroll, Jane L. Liesveld, Megan Baumgart, Sandra Sabtka, Dwight Hettler, Nicole Kaplan, Jason H. Mendler, Kah Poh Loh
Journal: Blood (2024)
Biomarker Correlates and Clinical Activity of Cevostamab in Patients (pts) with Triple-Class Refractory Multiple Myeloma (MM) Who Have Received ≥1 Prior B-Cell Maturation Antigen (BCMA)-Targeted Bispecific Antibody (BsAb): Results from the Phase I/II CAMMA 2 Study
Authors: Michel Delforge, Joshua Richter, Yael C. Cohen, Paolo Corradini, Douglas W Sborov, Alexander M. Lesokhin, Jesus G Berdeja, Moshe E Gatt, Laura Paris, Laura Rosinol Dachs, Hang Quach, Manisha Kanwar, Olivier Catalani, Paresh Sewpaul, Elisabeth Wassner-Fritsch, Ameet Mishra, Kerstin Trunzer, Shaji Kumar
Journal: Blood (2024)
Association of Race, Ethnicity, and Social Deprivation on the Incidence and Severity of Adverse Events in Induction in Children with Acute Lymphoblastic Leukemia
Authors: Jason M Stevenson, Anjali Khanna, Ashleigh Hawk, Avery Morse, Oyin Alao, Katherine Jordan, Xu Ji, Heeju Sohn, Sharon M. Castellino, Tamara P. Miller
Journal: Blood (2024)
Patient-Reported Quality of Life Outcomes with Venetoclax-Based First-Line Combinations in CLL: An Analysis from the Phase 3 GAIA/CLL13 Trial
Authors: Moritz Fürstenau, Emelie Curovic Rotbain, Laura Eurelings, Sandra Robrecht, Julia Von Tresckow, Adam Giza, Michael Gregor, Patrick Thornton, Philipp Bernhard Staber, Tamar Tadmor, Vesa Lindström, Gunnar Juliusson, Ann Janssens, Christof Schneider, Thomas Noesslinger, Martin Andres, Adrian Schmidt, Elisabeth Vandenberghe, Lev Shvidel, Christian Bjørn Poulsen, Henrik Frederiksen, Caspar Da Cunha-Bang, Kourosh Lotfi, Rogier Mous, Martine E.D. Chamuleau, Ka Lung Wu, Margriet Oosterveld, Jesus Duque-Afonso, Christian Bogner, Thomas Wolff, Johannes Schetelig, Ursula Vehling-Kaiser, Christoph van Roye, Nadine Kutsch, Anna Maria Fink, Kirsten Fischer, Emily Holmes, Matthias Ritgen, Eugen Tausch, Stephan Stilgenbauer, Michael J. Hallek, Arnon P. Kater, Carsten Utoft Niemann, Mark-David Levin, Barbara F. Eichhorst
Journal: Blood (2024)
Frailty Subgroups Determine Heterogeneous Outcomes in Elderly Patients with Newly-Diagnosed Multiple Myeloma - Long-Term Follow-up of the HOVON 143 Trial
Authors: Febe Smits, Kaz Groen, Mark-David Levin, Claudia A M Stege, Roel JW van Kampen, Ellen Van Der Spek, Yavuz M. Bilgin, Noortje Thielen, Inger S. Nijhof, Inge Ludwig, Esther G.M. De Waal, Yorick Sandberg, Alain Kentos, Gert Jan Timmers, Josien C Regelink, Matthijs Westerman, Koen de Heer, Marie Christiane Vekemans, Nazik Durdu-Rayman, Nicole de Graauw, Maarten R. Seefat, Niels W.C.J. van de Donk, Paula F Ypma, Kazem Nasserinejad, Sonja Zweegman
Journal: Blood (2024)
Chidamide: A New Exploration of Maintenance Therapy for DLBCL Patients with HBV Infection
Authors: Ying Zhang, Wei Guo, Yangzhi Zhao, Zhumei Zhan, Haotian Wang, Zhe Li, Bowen Wang, Luming Cao, Xin Wan, Jia Li, Ou Bai
Journal: Blood (2024)
Early Leukapheresis in Patients with B-ALL Yields an Activated, Early Memory T-Cell Phenotype Associated with Response to CAR T-Cell Therapy
Authors: Alexandra Dreyzin, Yihua Cai, Kyu Lee Han, Michaela Prochazkova, Jennifer Webb, Keri Toner, Kathryn Bushnell, Bonnie Yates, Ping Jin, David F. Stroncek, Nirali N. Shah
Journal: Blood (2024)
Clinical Implications of Central Nervous System Involvement in Acute Myeloid Leukemia
Authors: Giovangiacinto Paterno, Flavia Mallegni, Elisa Buzzatti, Maria Irno Consalvo, Elisa Meddi, Federico Moretti, Lucrezia De Marchi, Kristian Taka, Camilla Page, Massimiliano Marinoni, Luca Maurillo, Carmelo Gurnari, Raffaele Palmieri, Francesco Buccisano, Adriano Venditti, Maria Ilaria Del Principe
Journal: Blood (2024)
Preclinical Proof-of-Concept of an mRNA-Based T Cell Engager Targeting BCMA, FcRH5, and GPRC5D for the Treatment of Multiple Myeloma
Authors: Maija Garnaas, Kristen Cowens, Zhen Zhang, Michael Deci, Maiko Obana, John Zielinski, Matthew Sullivan, Russell Karp, Stephanie Christainsen, Brianna Magliozzi, Graham MacLean, Terrence Washington, Ying Fu, Varun Chavada, Hannah D'Ambrosio, Sunil Singh, John Eldredge, Kenneth Drombosky, Pradeep Babu Jagadeesh Reddy, Shilpa Sharma, Harkewal Singh, Neeraj Kaushal, Binu Philip, Graham Farrington, Brendan M. Weiss, Joshua P Frederick, Lin Guey
Journal: Blood (2024)
Cerebral Hemodynamics Improve in Adults with Sickle Cell Disease after Gene Therapy
Authors: Akshay Sharma, Jane S Hankins, Jaap Jan Boelens, Maria Cancio, Radhika Peddinti, Lawrence Rispoli, Sarah Sloan, Sarah DiDominick Costa, Sharon Peled, Andrea Wiethoff, James LaBelle
Journal: Blood (2024)
Prior Exposure to Belantamab Mafodotin Influences Outcomes with Idecabtagene Vicluecel in Patients with Multiple Myeloma
Authors: Bhavesh Mohan Lal, Marah Alzubi, Jawad Alrawabdeh, John D Shaughnessy, Jr, Fenghuang Zhan, Eric Siegel, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, Samer Al Hadidi
Journal: Blood (2024)
Bridging Radiotherapy to Axicabtagene Ciloleucel (axi-cel) Is Associated with Favourable Outcomes for Large B-Cell Lymphoma (LBCL) in Third-Line and Beyond: An Australian Single-Centre Real-World Experience
Authors: Hamish W Scott, Mark R Dowling, Daniel Garcia, Samantha van der Linde, Nicole O'Leary, Brydon Panozzo, Adrian Minson, James A Kuzich, Aaron Jun Ning Wong, Michael S Hofman, Monique Youl, Belinda Campbell, Michael Patrick Macmanus, Philip A. Thompson, Mary Ann Anderson, John F. Seymour, Michael J Dickinson, Simon J Harrison
Journal: Blood (2024)
Identifying 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA and Treatment Response in Multiple Myeloma with a Multi-Step Machine Learning Approach
Authors: Bei Wang, Benjamin A Derman, Zhou Zhang, Krissana Kowitwanich, John F. Cursio, Daniel Appelbaum, Chuan He, Wei Zhang, Andrzej J Jakubowiak, Brian Chiu
Journal: Blood (2024)
A <i>JAK2</i> Germline Variant Modulates Cytokine Release from Stromal Niche Cells and Induces Remodeling of the Bone Marrow Niche
Authors: Komei Nishimura, Yuka Sugimoto, Keiki Nagaharu, Ryoichi Ono, Takuya Tsuji, Akihide Nakamura, Eiko Ohya, Isao Tawara, Tetsuya Nosaka, Kohshi Ohishi
Journal: Blood (2024)
Gene Expression Profile of Enriched T-Cells Prior to Chimeric Antigen Receptor (CAR) T-Cell Manufacturing Is Predictive of CAR T-Cell Response
Authors: Bee S Tan, Charles Yin, Pankajkumar Tailor, Bindu Thapa, Carina Debes-Marun, Deanna Hockley, Irwindeep Sandhu, Michael P. Chu
Journal: Blood (2024)
Identification of Tumor Suppressors and Synthetic Lethal Targets in -7/del7q Myeloid Neoplasms By Iterative Computational Analysis Coupled with Experimental Validation
Authors: Daniel J Vail, Valeria Visconte, Babal K. Jha, Jill Durkin, Jaroslaw Maciejewski, Thomas Laframboise
Journal: Blood (2024)
Treatment in Clinical Trials Could Potentially Overcome the Disparity in Outcomes of Patients with Acute Myeloid Leukemia from Disadvantaged Neighborhoods
Authors: Mahesh Swaminathan, Hussein A. Abbas, Guillermo Garcia-Manero, Naval Daver, Tapan M. Kadia, Courtney D. DiNardo, Gautam Borthakur, Elias Jabbour, Naveen Pemmaraju, Yesid Alvarado Valero, Maro Ohanian, Nitin Jain, Nicholas J. Short, Prithviraj Bose, Koichi Takahashi, Hyunsoo Hwang, Xuelin Huang, Paul Edelkamp, Sherry Pierce, Uday Popat, Elizabeth J. Shpall, Richard E. Champlin, Hagop M. Kantarjian, Farhad Ravandi
Journal: Blood (2024)
Rapid and Sustained Recovery of Cellular Immunity in Patients with Myelofibrosis on Momelotinib Therapy
Authors: Jasmine Makker, Kyaw Htin Thaw, Amna Sheikh, Llywelyn Cadman-Davies, Andrea Duminuco, Elena Torre, Claire Woodley, Susan Asirvatham, Jennifer O' Sullivan, Natalia Curto-Garcia, Priya Sriskandarajah, Deepti H. Radia, Hugues de Lavallade, Shahram Kordasti, Claire Harrison, Patrick Harrington
Journal: Blood (2024)